The upregulation of lncRNA HANR in HCC promotes the occurrence of lymphangiogenesis via binding to miR-296 and inhibiting the EAG1/VEGF-A pathway in HLECs (Shi et al., 2019). This evidence concerns the gene VEGFA and hepatocellular carcinoma.